Furthermore,in vitroandin vivo analyses demonstrate that TMEM106A knockdown promotes HCC progression by inducting EMT through the Erk1/2/Slug signaling pathway which may serve as a potential therapeutic target. Here, MAPK3 is linked to hepatocellular carcinoma.